Provided by Tiger Trade Technology Pte. Ltd.

Merck

147.76
-0.5900-0.40%
Pre-market: 148.340.5800+0.39%04:35 EDT
Volume:11.13M
Turnover:1.64B
Market Cap:364.55B
PE:116.09
High:148.69
Open:147.00
Low:145.95
Close:148.35
52wk High:156.92
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:1.03
T/O Rate:0.45%
Dividend:3.32
Dividend Rate:2.25%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.69
PE(LYR):20.30

Loading ...

Rothschild & Co Redburn Adjusts Price Target on Merck to $145 From $140

MT Newswires Live
·
Jul 06

U.S. Research Roundup-east West Bancorp, First Citizens Bancshares, UMB Financial

Reuters
·
Jul 06

Is Merck’s Expanding Oncology, Vaccine and HIV Portfolio Altering The Investment Case For Merck (MRK)?

Simply Wall St.
·
Jul 03

Merck & Co. Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 03

Sector Update: Healthcare Stocks Gain Thursday Afternoon

MT Newswires Live
·
Jul 03

Movement Alert|Merck Rises 3.02% in Regular Trading, Multiple Banks Raise Price Targets Amid Promising Lung Cancer Drug Outlook

Market Focus
·
Jul 02

Blackrock Trims Merck Stake to 8.02% from 8.08%

Reuters
·
Jul 02

Merck terminates Phase 2 Alzheimer’s study

TIPRANKS
·
Jul 02

Press Release: Merck to Hold Second-quarter 2026 Sales and Earnings Conference Call Aug. 4

Dow Jones
·
Jul 01

Merck Schedules Second-quarter 2026 Sales and Earnings Conference Call

Reuters
·
Jul 01

Sector Update: Healthcare Stocks Decline Tuesday Afternoon

MT Newswires Live
·
Jul 01

Merck's Lung Cancer Drug Seen Boosting Sales Potential, BofA Says

MT Newswires Live
·
Jun 30

Merck is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
Jun 30

BofA Securities Adjusts Merck Price Target to $141 From $130, Maintains Buy Rating

MT Newswires Live
·
Jun 30

U.S. Stocks on the Move-aerovironment, Oklo

Reuters
·
Jun 30

Market Chatter: AbbVie, Merck Investigated by US House Committee Over Clinical Trials in China

MT Newswires Live
·
Jun 30

Broadcom Stock And Two AI Automation Picks Backed By Cash Flow

Simply Wall St.
·
Jun 30

Merck & Co Inc : Bofa Global Research Raises Price Objective to $141.00 from $130.00

THOMSON REUTERS
·
Jun 30

Analysts Have Conflicting Sentiments on These Healthcare Companies: Outlook Therapeutics (OTLK), Praxis Precision Medicines (PRAX) and Merck & Company (MRK)

TIPRANKS
·
Jun 30

Merck Down 1.2%, Abbvie Down 1%

THOMSON REUTERS
·
Jun 30